These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 23872464)

  • 1. I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial.
    Kranke P; Eberhart L; Motsch J; Chassard D; Wallenborn J; Diemunsch P; Liu N; Keh D; Bouaziz H; Bergis M; Fox G; Gan TJ
    Br J Anaesth; 2013 Dec; 111(6):938-45. PubMed ID: 23872464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Amisulpride for the Prevention of Postoperative Nausea and Vomiting: Two Concurrent, Randomized, Double-blind, Placebo-controlled Trials.
    Gan TJ; Kranke P; Minkowitz HS; Bergese SD; Motsch J; Eberhart L; Leiman DG; Melson TI; Chassard D; Kovac AL; Candiotti KA; Fox G; Diemunsch P
    Anesthesiology; 2017 Feb; 126(2):268-275. PubMed ID: 27902493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amisulpride for the Rescue Treatment of Postoperative Nausea or Vomiting in Patients Failing Prophylaxis: A Randomized, Placebo-controlled Phase III Trial.
    Habib AS; Kranke P; Bergese SD; Chung F; Ayad S; Siddiqui N; Motsch J; Leiman DG; Melson TI; Diemunsch P; Fox GM; Candiotti KA
    Anesthesiology; 2019 Feb; 130(2):203-212. PubMed ID: 30475232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous buspirone for the prevention of postoperative nausea and vomiting.
    Kranke P; Röhm KD; Diemunsch P; Gan TJ; Apfel CC; Eberhart L; Minkowitz HS; Wallenborn J; Chassard D; Lebuffe G; Fox GM; Tramèr MR
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1465-72. PubMed ID: 22546895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amisulpride Prevents Postoperative Nausea and Vomiting in Patients at High Risk: A Randomized, Double-blind, Placebo-controlled Trial.
    Kranke P; Bergese SD; Minkowitz HS; Melson TI; Leiman DG; Candiotti KA; Liu N; Eberhart L; Habib AS; Wallenborn J; Kovac AL; Diemunsch P; Fox G; Gan TJ
    Anesthesiology; 2018 Jun; 128(6):1099-1106. PubMed ID: 29543631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Amisulpride as Treatment of Established Postoperative Nausea and Vomiting in Patients Who Have Had No Prior Prophylaxis.
    Candiotti KA; Kranke P; Bergese SD; Melson TI; Motsch J; Siddiqui N; Chung F; Rodriguez Y; Minkowitz HS; Ayad SS; Diemunsch P; Fox G
    Anesth Analg; 2019 Jun; 128(6):1098-1105. PubMed ID: 31094774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol.
    Piper SN; Röhm K; Boldt J; Kranke P; Maleck W; Seifert R; Suttner S
    J Craniomaxillofac Surg; 2008 Apr; 36(3):173-179. PubMed ID: 18353666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, double-blind, placebo-controlled study to assess the antiemetic effects of midazolam on postoperative nausea and vomiting in women undergoing laparoscopic gynecologic surgery.
    Fujii Y; Itakura M
    Clin Ther; 2010 Aug; 32(9):1633-7. PubMed ID: 20974320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial.
    Ryu JH; Jeon YT; Hwang JW; Oh AY; Moon JY; Ro YJ; Kim CS; Chen C; Apfel CC; Do SH
    Clin Ther; 2011 Sep; 33(9):1162-72. PubMed ID: 21856001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dolasetron, droperidol and a combination of both in prevention of postoperative nausea and vomiting after extracapsular cataract extraction under general anesthesia].
    Eberhart LH; Lindenthal M; Seeling W; Gäckle H; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):345-9. PubMed ID: 10429772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.
    Dewinter G; Teunkens A; Vermeulen K; Devroe S; Van Hemelrijck J; Meuleman C; Vergote I; Fieuws S; Van de Velde M; Rex S
    Eur J Anaesthesiol; 2016 Feb; 33(2):96-103. PubMed ID: 26086285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Droperidol and dimenhydrinate alone or in combination for prevention of postoperative nausea and vomiting].
    Eberhart LH; Seeling W; Morin AM; Vogt N; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 May; 36(5):290-5. PubMed ID: 11413698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inspired oxygen fraction of 0.8 compared with 0.4 does not further reduce postoperative nausea and vomiting in dolasetron-treated patients undergoing laparoscopic cholecystectomy.
    Piper SN; Röhm KD; Boldt J; Faust KL; Maleck WH; Kranke P; Suttner SW
    Br J Anaesth; 2006 Nov; 97(5):647-53. PubMed ID: 16963789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting.
    Fox GM; Albayaty M; Walker JL; Xue H; Darpo B
    Anesth Analg; 2021 Jan; 132(1):150-159. PubMed ID: 31913911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery.
    Kim SI; Kim SC; Baek YH; Ok SY; Kim SH
    Br J Anaesth; 2009 Oct; 103(4):549-53. PubMed ID: 19700442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting.
    Smyla N; Koch T; Eberhart LH; Gehling M
    Expert Opin Pharmacother; 2020 Apr; 21(5):517-522. PubMed ID: 31971450
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period.
    Kovac AL; Eberhart L; Kotarski J; Clerici G; Apfel C;
    Anesth Analg; 2008 Aug; 107(2):439-44. PubMed ID: 18633021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of postoperative nausea and vomiting in elective breast surgery.
    Voigt M; Fröhlich CW; Waschke KF; Lenz C; Göbel U; Kerger H
    J Clin Anesth; 2011 Sep; 23(6):461-8. PubMed ID: 21911192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting.
    Candiotti KA; Kovac AL; Melson TI; Clerici G; Joo Gan T;
    Anesth Analg; 2008 Aug; 107(2):445-51. PubMed ID: 18633022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.